Beyond conventional treatments: cutting-edge strategies for ascites in cirrhosis.

Authors

Weimiao Lin, Wenjin Fan, Lei Xu, Lihong Mao

Published in

Frontiers in medicine. Volume 13. Pages 1918993. Epub Sep 28, 2026.

Abstract

Ascites is a prevalent complication in cases of decompensated liver cirrhosis, having a considerable effect on the quality of life and prognosis of patients. Current treatment methods of ascites in cirrhosis primarily include conventional diuretics, paracentesis, albumin infusion, transjugular intrahepatic portosystemic shunt (TIPS), and liver transplantation. However, these approaches are associated with certain limitations and risks. In recent years, novel therapeutic strategies targeting distinct pathophysiological pathways of ascites have continued to emerge, including sodium-glucose cotransporter 2 (SGLT2) inhibitors, vasopressin analogues, regenerative medicine, and gut microbiota modulation. The present review focuses on emerging pharmacological strategies for ascites in cirrhosis, systematically summarizes their mechanisms of action, and discusses their efficacy, safety, and limitations, while also outlining future research directions.

PMID:
42865639
Bibliographic data and abstract were imported from PubMed on 13 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.